Colorectal Cancer Screening in Vulnerable Patients by Brenner, Alison T. et al.
Colorectal Cancer Screening in Vulnerable Patients:
Promoting Informed and Shared Decisions
Alison T. Brenner, PhD1,2,3, Richard Hoffman, MD, MPH4,5, Andrew McWilliams, MD, MPH6, 
Michael P. Pignone, MD, MPH1,2,3, Robert L. Rhyne, MD, MPH7,8, Hazel Tapp, PhD6, Mark A. 
Weaver, PhD2,9, Danelle Callan, MA8, Brisa Urquieta de Hernandez, BUS6, Khalil Harbi, 
MSPH1, and Daniel S. Reuland, MD, MPH1,2,3
1Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, 
North Carolina
2Division of General Internal Medicine, University of North Carolina School of Medicine, Chapel 
Hill, North Carolina
3Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North 
Carolina
4Division of General Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, 
Iowa
5Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa
6Department of Family Medicine, Carolinas HealthCare System, Charlotte, North Carolina
7Department of Family and Community Medicine, University of New Mexico School of Medicine, 
Albuquerque, New Mexico
8University of New Mexico Cancer Center, Albuquerque, New Mexico
9Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina
Abstract
Introduction—Low-income, low-literacy, limited English–proficient populations have low 
colorectal cancer (CRC) screening rates and experience poor patient–provider communication and 
decision-making processes around screening. The purpose of this study was to test the effect of a 
CRC screening decision aid on screening-related communication and decision making in primary 
care visits.
Study design—RCT with data collected from patients at baseline and immediately after the 
provider encounter.
Setting/participants—Patients aged 50–75 years, due for CRC screening, were recruited from 
two safety net clinics in North Carolina and New Mexico (data collection, January 2014–
September 2015; analysis, 2015).
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Intervention—Participants viewed a CRC screening decision aid or a food safety (control) video 
immediately before their provider encounter.
Main outcome measures—CRC screening–related knowledge, discussion, intent, test 
preferences, and test ordering.
Results—The study population (N=262) had a mean age of 58.3 years and was 66% female, 61% 
Latino, 17% non-Latino black, and 16% non-Latino white. Among Latino participants, 71% 
preferred Spanish. Compared with controls, intervention participants had greater screening-related 
knowledge (on average 4.6 vs 2.8 of six knowledge items correct, adjusted difference [AD]=1.8, 
95% CI=1.5, 2.1) and were more likely to report screening discussion (71.0% vs 45.0%, 
AD=26.1%, 95% CI=14.3%, 38.0%) and high screening intent (93.1% vs 84.7%, AD=9.0%, 95% 
CI=2.0%, 16.0%). Intervention participants were more likely to indicate a specific screening test 
preference (93.1% vs 68.0%, AD=26.5%, 95% CI=17.2%, 35.8%) and to report having a test 
ordered (56.5% vs 32.1%, AD=25.8%, 95% CI=14.4%, 37.2%).
Conclusions—Viewing a CRC screening decision aid before a primary care encounter improves 
knowledge and shared decision making around screening in a racially, ethnically, and linguistically 
diverse safety net clinic population.
Trial registration—This study is registered at www.clinicaltrials.gov NCT02054598.
Introduction
Colorectal cancer (CRC) is the third leading cause of cancer death in men and women in the 
U.S.1 CRC screening is effective at reducing CRC mortality. Expert groups, such as the U.S. 
Preventive Services Task Force, recommend a variety of tests for initial CRC screening, 
including fecal occult blood testing or fecal immunochemical testing (FOBT/FIT), with 
either guaiac-based or immunochemical tests, and endoscopic tests, typically with 
colonoscopy.2,3 Unfortunately, screening is underutilized, especially among vulnerable 
populations, including those with low income, low educational attainment, and limited 
English proficiency.4–10
Among the many barriers to screening in these populations are lack of patient awareness of 
screening options and not having a doctor recommend or discuss screening options during 
primary care visits.8,11–14 Studies also suggest that the way in which CRC screening is 
discussed and offered in clinical settings is important. When appropriately informed, 
primary care patients have distinct preferences for screening tests and are more likely to 
complete screening when their provider recommends a screening test that they prefer.15,16 
However, studies also show that patients and physicians often have different screening test 
preferences, physicians are more likely than patients to prefer colonoscopy over stool-based 
tests, and physicians often misperceive or fail to acknowledge patients’ screening 
preferences, especially when they differ from their own.17–20 This suggests that improving 
informed decision making, through improved patient knowledge about CRC screening 
options, as well as shared decision making, through physician offering of a choice of tests 
and incorporation of patient test preference into the recommendation, may be effective at 
overcoming some barriers to screening.
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Studies also suggest that improving screening-related communication by offering patients a 
choice of screening tests that includes FOBT/FIT may be especially important for vulnerable 
population subgroups such as Latinos and others served in safety net care settings. Hawley et 
al.17 showed that Latinos and those with lower educational attainment were more likely to 
prefer FOBT/FIT than non-Latino whites and those with more education. Inadomi and 
colleagues21 found that in a diverse, low-income population, participants for whom 
colonoscopy only was recommended were less likely to complete screening (38%) than 
participants receiving a recommendation for FOBT/FIT only (67%) or a choice between 
FOBT/FIT or colonoscopy (69%). They also found that Latino participants completed 
FOBT/FIT more often, whereas white participants completed colonoscopy more often. This 
demonstrated preference for FOBT/FIT among Latinos and those with lower educational 
attainment, juxtaposed with typical provider preference for colonoscopy, may contribute to 
lower screening completion rates. Based on these findings, experts in the field have 
emphasized the need to promote informed and shared decision making about CRC 
screening, which includes communication between patient and provider about screening and 
screening test options.22,23 However, this may be especially challenging in safety net care 
settings, where provider-level barriers, such as limited visit time and competing demands, 
are compounded by patient-level barriers that include language and literacy differences.24–29
Decision aids are useful in healthcare decisions where more than one reasonable option 
exists. They can improve the decision-making process and can lead to more informed, 
values-based choices.22 When delivered in a multimedia format before a primary care 
encounter, decision aids can mitigate literacy barriers and permit providers to use limited 
clinical time to clarify and act more specifically on informed patient preferences. CRC 
screening decision aids have been shown to increase screening knowledge, test ordering, 
intent to complete screening, discussion of screening, and (in some studies) test 
completion.30–33 However, no prior studies were found that have demonstrated that a CRC 
screening decision aid or educational video meaningfully increases discussion of more than 
one screening test option (a proxy for shared decision making).34 Further, although a few 
CRC decision aid studies have enrolled diverse, vulnerable patient populations,33,35 there is 
a need to identify screening interventions that are effective in Latino populations, who have 
substantially lower screening rates than the general U.S. population.36 However, no U.S. 
clinical trials of CRC screening decision aids conducted in Spanish-speaking populations 
were found.
The primary objective of this study was to test the effect of a CRC screening decision aid, 
available in English31,37 and Spanish,38 and viewed before a primary care encounter, on 
patient-reported communication and decision-making outcomes in a racially and ethnically 
diverse safety net clinic population. To improve generalizability, study sites, described 
below, were selected in locations representative of new and established socio-historic 
immigration contexts.39,40 The hypothesis was that the decision aid would lead to 
improvements in outcomes relevant for informed and shared decision making, including 
screening-related knowledge, communication about CRC screening and test options, 
preference formation, and test ordering among the overall study population as well as the 
Latino subgroup.
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Methods
Overview
Data were collected from January 2014 to September 2015, and analyzed in 2015, as part of 
the CHOICE/OPCIONES study. The study design is reported in detail elsewhere,41 but 
briefly, the trial was designed to test a two-part intervention including a CRC screening 
decision aid, delivered before the provider encounter, and patient navigation, delivered after 
the provider encounter. Outcomes reported here reflect the effect of the decision aid part of 
the intervention on communication and decision-making outcomes assessed via survey 
directly after the provider encounter (and prior to initiation of the patient navigation 
intervention). Screening completion outcomes (to be published separately) will be assessed 
by electronic health record review in 2016 and will reflect the additional effect of the second 
part of the intervention, delivered after the collection of the post-encounter survey measures 
reported here. This study was approved by the IRBs at the University of North Carolina at 
Chapel Hill, the University of New Mexico, and Carolinas HealthCare System.
Study Sites
Participants were recruited from two safety net clinic sites, one in Albuquerque, New 
Mexico, and one in Charlotte, North Carolina. The sites were selected because they serve 
diverse low-income communities that include substantial numbers of Latino patients. 
Additionally, the sites reflect two distinct immigration patterns within the U.S.: North 
Carolina is typical of U.S. regions where Latino immigration has been both new and rapid in 
recent decades, whereas New Mexico is representative of regions with established, 
multigenerational Latino populations.39,40 These sites were selected to improve 
generalizability of the findings across U.S. Latino populations.
Recruitment and Study Activities
Potentially eligible patients were identified by querying the practices’ appointment 
schedules. A research assistant reviewed electronic medical records for evidence of current 
CRC screening according to guidelines. The research assistant then attempted to contact 
potentially eligible patients before their upcoming visit or approached them on the day of the 
visit to invite them to participate. On the day of the physician visit, eligible and consented 
patients completed a baseline survey and were randomized to view the CRC screening 
decision aid or the control video before the physician encounter. After the provider 
encounter, participants completed a follow-up survey. All surveys were available in English 
and Spanish and were administered orally by a study team member; participants followed 
along and indicated their answer choice to the study team member (Appendix 1, available 
online).
Decision Aids
Development and prior testing of the Spanish (OPCIONES) and English (CHOICE) decision 
aids is described in detail in other publications.31,33,37,38,42 Both versions are approximately 
14 minutes long and consist of three parts: (1) introduction and review of fecal testing 
(FOBT/FIT) and colonoscopy; (2) direct comparison of the features of the two testing 
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options; and (3) screening readiness assessment, in which viewers are prompted to select one 
of three color-coded, printed brochures indicating their screening readiness.
Outcome Measures
Outcomes measured (Table 1) for this study included CRC screening–related knowledge, 
discussion, test preference, intent to be screened, and test ordering. Screening knowledge 
was assessed at baseline and post-encounter using six previously tested items.33,42 Screening 
discussion was measured using two items administered post-encounter follow-up survey. 
Intent to complete screening was assessed at baseline and post-encounter using a 5-point 
Likert-scale response that was dichotomized for analysis (bottom three versus top two 
categories). Screening test preference was assessed using one item on the post-encounter 
survey. Test ordering was assessed using three items on the post-encounter survey.
Analytic Approach
Outcomes were compared using randomization-based nonparametric methods with a 
modified intention-to-treat approach that excluded all participants who provided no follow-
up data. Although randomization was stratified by site, it was important to control for 
potential outcome variation across providers, who were nested within site. Therefore, 
analyses were conducted with stratification adjustment for providers, for which the data for 
lowest volume providers were combined in each site to ensure that each stratum included 
participants from each group (data were combined for three North Carolina providers, out of 
eight, who saw a total of 15 participants, and for six New Mexico providers, out of 27, who 
saw a total of eight participants). For screening discussion, test preference, and test ordering, 
which were only measured at follow-up, a stratified Mantel–Haenszel row mean score test 
was applied.43 For screening knowledge and intent, a stratified nonparametric ANCOVA, 
controlling for baseline value, was applied.43 Because these outcomes were pre-specified as 
secondary outcomes for this trial,41 each was tested using a two-sided 0.05 significance 
level, with no adjustments for multiple comparisons. Mantel–Haenszel weights were used to 
estimate adjusted differences along with 95% CIs. To explore the potential for 
heterogeneous effects across sites, generalized estimating equation methods were used to 
test site-by-group interactions at the 0.05 level; where interaction tests were significant, 
estimated effects within each site were reported. In a separate pre-planned analysis, the 
effect of the intervention among Latino participants only was tested. Analyses were 
conducted using SAS, version 9.4; nonparametric ANCOVA was conducted using the SAS 
macro NparCov3.44
Results
A total of 267 participants were enrolled and randomized (134 intervention, 133 control) 
between January 2014 and August 2015. Of these, 262 had complete data and were included 
in the analysis (Figure 1) (excluded were three intervention, two control). Participants had a 
mean age of 58.4 years, 65% were female, 61% were Latino, 17% non-Latino black, and 
16% non-Latino white. Most (77%) had a household income <$20,000, 39% had a limited 
health literacy,45 and 34% were uninsured. Among Latino participants, 71% reported 
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Spanish as the preferred language. There were no notable differences between groups at 
baseline (Table 2).
The participants enrolled in New Mexico (n=161) were predominantly Latino (75%) or non-
Latino white (18%), whereas those recruited in North Carolina (n=101) were non-Latino 
black (42%), Latino (39%), or non-Latino white (12%). Additionally, participants in New 
Mexico (where Medicaid expansion was adopted) were more likely to have Medicaid than 
those in North Carolina (where Medicaid expansion was not adopted) (35% vs 18%, 
respectively). Otherwise, participants at the two sites were not notably different.
Intervention participants showed greater improvement in knowledge from baseline to 
follow-up than did control participants (Table 3). The mean adjusted difference (AD) in 
post-intervention knowledge was 1.8 knowledge items (95% CI=1.5, 2.1) correct on a 6-item 
scale. Improvement was observed for each of individual knowledge items as well (data not 
shown).
Intervention participants were more likely to report discussing any CRC screening test with 
their provider (AD=26.1%, 95% CI=14.3%, 38.0%). The increase was due principally to 
more discussion of FOBT/FIT and discussion of both tests (Table 3).
A substantial majority of participants expressed high screening intent at baseline (70.2% 
intervention vs 71.8% control), and the proportion expressing high intent increased in both 
groups at follow-up (93.1% intervention vs 84.7% control). The increase in the proportion 
with high intent to be screened was greater in the intervention group (AD=9.0%, 95% 
CI=2.0%, 16.0%).
Intervention participants were more likely to indicate a particular test preference than 
controls (AD=26.5%, 95% CI=17.2%, 35.8%). Preference for colonoscopy was similar 
across arms (26.0% intervention vs 22.2% control), whereas reported preference for 
FOBT/FIT was substantially greater among intervention patients (67.1% intervention vs 
45.8% control).
Intervention participants were more likely to report that their provider ordered a CRC 
screening test (AD=25.8%, 95% CI=14.4%, 37.2%). Colonoscopy ordering was only 
modestly different across groups (17.6% intervention vs 13.0% control), whereas FOBT/FIT 
ordering was twice as high in the intervention arm (35.9% intervention vs 18.3% control). 
Similar effects on knowledge, discussions, intent, and test ordering were observed when the 
analysis was restricted to Latino participants only (Appendix 2, available online).
The intervention was effective at both sites. However, there was evidence of heterogeneity of 
effects across sites on knowledge (p<0.001; mean difference of 2.3 in North Carolina [95% 
CI=1.9, 2.7] and 1.5 in New Mexico [95% CI=1.2, 1.8]) and on screening discussion 
(p=0.015; mean difference of 41.6% in North Carolina [95% CI=29.1%, 54.1%] and 17.3% 
in New Mexico (95% CI=2.2%, 32.5%). There was no evidence of heterogeneity of effects 
across sites on intent to be screened (p=0.642); test preference (p=0.136); or test ordering 
(p=0.185).
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Discussion
In this trial conducted in safety net clinics in the U.S., a CRC screening decision aid 
improved knowledge, communication, and decision-making outcomes. The finding that 
decision aid viewing increased knowledge about CRC screening is consistent with other 
U.S. decision aid studies in English-speaking populations30,35,37,46–48 and with the prior test 
of the Spanish language decision aid in a non-clinical setting.42 Although there is no 
consensus on what type of knowledge is necessary for “informed” decision making, the 
knowledge items assessed information that is decision relevant. For example, the items 
assess understanding about some of the key ways in which the two screening test options 
differ (e.g., testing frequency) and awareness that there is more than one test option 
available. Further, apart from higher knowledge scores, participants viewing the decision aid 
were more likely to be able to indicate a specific test preference and less likely to indicate 
that they “didn’t have enough information to decide.” Taken together, the findings suggest 
that the decision aid improved informed decision making about CRC screening.
Beyond showing that the decision aid leads to more-informed decision making, the findings 
also suggest that this intervention improves patient–provider communication about CRC 
screening. Specifically, intervention participants were more likely to report having a 
discussion about CRC with their providers, and were nearly three times as likely to report 
discussions about both fecal and endoscopic screening tests (a potential proxy for shared 
decision making). This suggests that using a decision aid in this context not only increases 
the frequency of screening-related communication, but also can improve the quality of that 
communication from a decision-making perspective. Although other CRC screening 
decision aid studies have assessed knowledge about CRC screening options and whether 
screening was discussed at all, this is the first study known to the authors to assess whether 
more than one screening option was discussed.
The importance of promoting high-quality clinical communication about CRC screening is 
twofold. First, having a provider’s recommendation to complete a CRC screening test, that 
is, any screening communication, has repeatedly been shown to be an important factor in 
promoting screening completion.12,13,49 Second, accumulating evidence suggests that a 
discussion in which the provider incorporates a patient’s screening test preferences, rather 
than simply recommending screening, is also important in promoting screening 
completion.17,30,50
This study also enhances knowledge about the potential role of multimedia decision aids in 
addressing screening disparities for Latino populations. Although other U.S. CRC screening 
decision aid studies have enrolled minority patient populations,32,33,51 this is the first such 
trial known to the authors to enroll Spanish-speaking Latino patients. Improving screening 
in Latino populations is important because they are the largest and fastest-growing racial/
ethnic minority group in the U.S.52 and have substantially lower screening rates than non-
Latinos.36 This screening disparity is particularly striking for Spanish-speaking Latinos. In 
one national survey study, 33% of Latinos responding in Spanish reported having had a CRC 
screening test, compared with 51% of Latinos responding in English and 62% of non-
Latinos.9 This study provides new evidence that a decision aid delivered in safety net care 
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settings where racially, ethnically, and linguistically diverse patients are served can promote 
meaningful participation in informed and shared medical decision making about CRC 
screening.
Limitations
This study has limitations. First, research staff were not masked to the participants’ assigned 
study arm, which could lead to bias in measurement of study outcomes. Second, screening 
communication and test ordering outcomes were patient-reported and could be inaccurate. 
Third, randomization at the individual patient level within these clinics may have caused 
some providers to change their usual care with respect to CRC screening communication 
and decision making as a result of exposure to intervention patients. However, such 
contamination would bias results toward null effect.
This study also has several strengths. First, the RCT design increases the likelihood that 
these findings are internally valid. Second, the study included a racially, ethnically, and 
linguistically diverse sample of patients, who are understudied but reflective of populations 
cared for in safety net clinic settings. Third, the intervention was effective at both New 
Mexico and North Carolina sites. Thus, the potential generalizability of the findings to 
clinics serving Latino communities is enhanced by the fact that data were collected in states 
representing two U.S. regions that differ substantially with respect to Latino immigration 
history.39,40 Fourth, clinical communication and decision-making outcomes were assessed 
immediately after provider encounters, making the findings about provider communication 
more robust than population survey studies, which are more prone to recall bias. Finally, 
there was minimal loss to follow-up (2%), reducing potential for selection bias.
Conclusions
This study found that a CRC screening decision aid before a primary care visit led to 
improvements in decision-relevant knowledge, clinical communication, and decision-making 
processes in a racially, ethnically, and linguistically diverse patient population. Using a CRC 
screening decision aid in this care context can help vulnerable patient populations participate 
meaningfully in informed and shared decision making about screening. The decision aids 
used in this study can be accessed with permission of the authors. Future research should 
continue to explore methods for sustainable implementation of decision aids combined with 
patient navigation in safety net, primary care settings.
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Appendix Supplementary data
Supplementary data associated with this article can be found at http://dx.doi.org/10.1016/
j.amepre.2016.03.025.
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Figure 1. 
CONSORT diagram.
*Missing one or more responses to outcome items
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Table 1
Communication and Decision-Making Outcome Measures
Survey Items Response choices
Knowledge assessment itemsa
 There is only one way to get screened for colon cancer. True, false,a don’t know
 It is possible to do a colon cancer screening test at home. True,a false, don’t know
 A person can drive his or her car home immediately after a colonoscopy. True, false,a don’t know
 There is no risk during the colonoscopy procedure. True, false,a don’t know
 The (stool) fecal occult blood test, or FOBT, should be done every three years. True, false,a don’t know
 At what age is it recommended that a person start getting screened for colon cancer? 35, 40, 45, 50,a 55 years
CRC screening communication assessment items
 Did you discuss colon cancer screening tests (such as colonoscopy or FOBT) with 
your doctor today?
Yes; no; don’t know
 [If yes] Which colon cancer screening tests did you discuss with your doctor today? FOBT only; colonoscopy only; FOBT and 
colonoscopy; don’t know
Intent to complete screening assessment item
 How much do you agree with the following statement? “I plan to be screened for 
colon cancer.”
Strongly disagree; disagree; neither agree nor 
disagree; agree; strongly agree
Test preference
 If you had to choose a colon cancer screening test, which test would you prefer? FOBT; colonoscopy; haven’t decided which test; 
don’t have enough information to know
Test ordering
 Did any of the following happen TODAY with your medical team? Did you get an 
FOBT kit (home stool test for blood)? Did your doctor refer you for a colonoscopy?
Yes; no; don’t know
aCorrect response for knowledge item.
CRC, colorectal cancer; FOBT, fecal occult blood testing.
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Table 2
Participant Characteristics by Study Arm
Factor Intervention (n=131) Control (n=131) All (n=262)
Age (mean years) 58.2 58.4 58.3
Sex
 Female 67% 64% 66%
Race/ethnicity
 Latino 56% 66% 61%
 Non-Latino black 18% 16% 17%
 Non-Latino white 17% 15% 16%
 Other 9% 3% 6%
Language preference
 Spanish 40% 47% 44%
Education
 Less than high school 46% 45% 45%
 High school or higher 54% 55% 55%
Married
 Married 48% 46% 47%
 Separated 6% 5% 5%
 Divorced 12% 22% 17%
 Widowed 12% 7% 10%
 Single/never 22% 20% 21%
Insurance
 None 34% 34% 34%
 Medicaid 29% 28% 29%
 Medicare 23% 27% 25%
 Private 14% 11% 12%
Annual income
 <$20,000 22% 23% 23%
 ≥$20,000 78% 77% 78%
Employment
 Not employed 74% 67% 71%
 Employed 26% 33% 30%
Health literacya
 Limited 43% 34% 39%
 Adequate 57% 66% 62%
a
From Chew et al. (2004).45
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Table 3
Patient-Reported Communication and Decision-Making Outcomes in Intervention Versus Control Participants
Intervention (n=131) Control (n=131) Adjusted differencea
Knowledgeb
 Baseline 2.6 2.5 —
 Follow-up 4.6 2.8 1.8 (1.5, 2.1)***
Screening discussion
 Any discussion 71.0% 45.0% 26.1% (14.3%, 38.0%)***
 FOBT only 29.8% 13.7%
 Colonoscopy only 15.3% 18.3%
 Both tests 24.4% 8.4%
 “Not sure which test” 1.5% 4.6%
 None 29.0% 55.0%
Intent to be screenedc
 Baseline 70.2% 71.8% —
 Follow-up 93.1% 84.7% 9.0% (2.0%, 16.0%)*
Test preference
 Any preference 93.1% 68.0% 26.5% (17.2% 35.8%)***
 FOBT 67.1% 45.8%
  Colonoscopy 26.0% 22.2%
  “Haven’t decided which test” 3.8% 10.7%
  “Don’t have enough information to decide” 3.1% 21.4%
Test ordering
 Any test ordered 56.5% 32.1% 25.8% (14.4%, 37.2%)***
 FOBT only 35.9% 18.3%
 Colonoscopy only 17.6% 13.0%
 Both tests 3.0% 0.8%
 None 43.5% 67.9%
aAll comparisons control for provider; comparisons for knowledge and intent also control for baseline. Boldface indicates statistical significance 
(*p<0.05; **p<0.001; ***p<0.001).
b
Mean number of correct responses out of six items.
c
Higher intent to be screened (strongly agree/agree) versus lower (strongly disagree/disagree/neutral).
FOBT, fecal occult blood testing.
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